围手术期24小时美罗培南与72小时美罗培南在泌尿外科手术中产esbl肠杆菌患者中的初步试验

IF 1.4 Q3 UROLOGY & NEPHROLOGY Central European Journal of Urology Pub Date : 2022-01-01 Epub Date: 2022-06-22 DOI:10.5173/ceju.2022.0109
Marcin Radko, Aneta Guzek, Tomasz Syryło, Zbigniew Rybicki, Henryk Zieliński
{"title":"围手术期24小时美罗培南与72小时美罗培南在泌尿外科手术中产esbl肠杆菌患者中的初步试验","authors":"Marcin Radko,&nbsp;Aneta Guzek,&nbsp;Tomasz Syryło,&nbsp;Zbigniew Rybicki,&nbsp;Henryk Zieliński","doi":"10.5173/ceju.2022.0109","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Antimicrobial prophylaxis is an important issue in positive urine culture patients undergoing endourological procedures or extracorporeal shock wave lithotripsy (ESWL). It is especially recognized in asymptomatic bacteriuria patients of alarm pathogen etiology. We designed a preliminary study to determine optimal duration of antibiotic prophylaxis in patients undergoing endourological procedures or ESWL with asymptomatic bacteriuria caused by <i>Enterobacterales</i> with extended spectrum beta-lactamase positive (ESBL+) type resistance.</p><p><strong>Material and methods: </strong>A total of 60 patients with confirmed ESBL+ <i>Enterobacterales</i> bacteriuria were admitted for endourological procedures or ESWL. The patients were randomized into two groups - a one-day (n = 33) and a three-day (n = 27) period of perioperative antibiotic prophylaxis with meropenem. In both groups on the following day after the procedure (24 hours after the procedure) and 7 days after the procedure serum inflammation markers were assessed.</p><p><strong>Results: </strong>Values of white blood count, C-reactive protein and procalcitonin prior to, 24 hours and seven days after the procedure clearly showed no statistically significant differences between groups that have received a one-day and three-day antibiotic regimen.</p><p><strong>Conclusions: </strong>In patients with ESBL+ <i>Enterobacterales</i> asymptomatic bacteriuria undergoing endourological procedures or ESWL a 72-hour perioperative meropenem prophylaxis showed no superiority over a 24-hour regimen. Further studies will be carried out to establish optimal prophylaxis for specific endourological procedures and to test safety of a single dose regimen.</p>","PeriodicalId":9744,"journal":{"name":"Central European Journal of Urology","volume":null,"pages":null},"PeriodicalIF":1.4000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ad/bd/CEJU-75-0109.PMC9326705.pdf","citationCount":"0","resultStr":"{\"title\":\"Preliminary trial of 24 vs 72 hour perioperative meropenem in patients with ESBL-producing <i>Enterobacterales</i> bacteriuria scheduled for urological procedures.\",\"authors\":\"Marcin Radko,&nbsp;Aneta Guzek,&nbsp;Tomasz Syryło,&nbsp;Zbigniew Rybicki,&nbsp;Henryk Zieliński\",\"doi\":\"10.5173/ceju.2022.0109\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Antimicrobial prophylaxis is an important issue in positive urine culture patients undergoing endourological procedures or extracorporeal shock wave lithotripsy (ESWL). It is especially recognized in asymptomatic bacteriuria patients of alarm pathogen etiology. We designed a preliminary study to determine optimal duration of antibiotic prophylaxis in patients undergoing endourological procedures or ESWL with asymptomatic bacteriuria caused by <i>Enterobacterales</i> with extended spectrum beta-lactamase positive (ESBL+) type resistance.</p><p><strong>Material and methods: </strong>A total of 60 patients with confirmed ESBL+ <i>Enterobacterales</i> bacteriuria were admitted for endourological procedures or ESWL. The patients were randomized into two groups - a one-day (n = 33) and a three-day (n = 27) period of perioperative antibiotic prophylaxis with meropenem. In both groups on the following day after the procedure (24 hours after the procedure) and 7 days after the procedure serum inflammation markers were assessed.</p><p><strong>Results: </strong>Values of white blood count, C-reactive protein and procalcitonin prior to, 24 hours and seven days after the procedure clearly showed no statistically significant differences between groups that have received a one-day and three-day antibiotic regimen.</p><p><strong>Conclusions: </strong>In patients with ESBL+ <i>Enterobacterales</i> asymptomatic bacteriuria undergoing endourological procedures or ESWL a 72-hour perioperative meropenem prophylaxis showed no superiority over a 24-hour regimen. Further studies will be carried out to establish optimal prophylaxis for specific endourological procedures and to test safety of a single dose regimen.</p>\",\"PeriodicalId\":9744,\"journal\":{\"name\":\"Central European Journal of Urology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ad/bd/CEJU-75-0109.PMC9326705.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Central European Journal of Urology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5173/ceju.2022.0109\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/6/22 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Central European Journal of Urology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5173/ceju.2022.0109","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/6/22 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

导读:在接受泌尿道手术或体外冲击波碎石术(ESWL)的尿培养阳性患者中,抗菌药物预防是一个重要问题。尤其在无症状的细菌性尿病患者中被认为是病原学上的警示。我们设计了一项初步研究,以确定由扩展谱β -内酰胺酶阳性(ESBL+)型耐药肠杆菌引起无症状细菌尿的患者接受泌尿道手术或ESWL的最佳抗生素预防时间。材料和方法:共60例确诊为ESBL+肠杆菌性细菌尿的患者接受了泌尿外科手术或ESWL。患者被随机分为两组——为期一天(n = 33)和三天(n = 27)的围手术期美罗培南抗生素预防。两组患者在术后第2天(术后24小时)和术后7天进行血清炎症指标测定。结果:术前、24小时和术后7天的白细胞计数、c反应蛋白和降钙素原值明显显示,接受1天和3天抗生素治疗的两组之间无统计学差异。结论:在ESBL+肠杆菌无症状细菌尿患者接受泌尿道手术或ESWL时,72小时围手术期预防美罗培南并没有优于24小时治疗方案。将进行进一步的研究,以确定特定泌尿系统手术的最佳预防方法,并测试单一剂量方案的安全性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Preliminary trial of 24 vs 72 hour perioperative meropenem in patients with ESBL-producing Enterobacterales bacteriuria scheduled for urological procedures.

Introduction: Antimicrobial prophylaxis is an important issue in positive urine culture patients undergoing endourological procedures or extracorporeal shock wave lithotripsy (ESWL). It is especially recognized in asymptomatic bacteriuria patients of alarm pathogen etiology. We designed a preliminary study to determine optimal duration of antibiotic prophylaxis in patients undergoing endourological procedures or ESWL with asymptomatic bacteriuria caused by Enterobacterales with extended spectrum beta-lactamase positive (ESBL+) type resistance.

Material and methods: A total of 60 patients with confirmed ESBL+ Enterobacterales bacteriuria were admitted for endourological procedures or ESWL. The patients were randomized into two groups - a one-day (n = 33) and a three-day (n = 27) period of perioperative antibiotic prophylaxis with meropenem. In both groups on the following day after the procedure (24 hours after the procedure) and 7 days after the procedure serum inflammation markers were assessed.

Results: Values of white blood count, C-reactive protein and procalcitonin prior to, 24 hours and seven days after the procedure clearly showed no statistically significant differences between groups that have received a one-day and three-day antibiotic regimen.

Conclusions: In patients with ESBL+ Enterobacterales asymptomatic bacteriuria undergoing endourological procedures or ESWL a 72-hour perioperative meropenem prophylaxis showed no superiority over a 24-hour regimen. Further studies will be carried out to establish optimal prophylaxis for specific endourological procedures and to test safety of a single dose regimen.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Central European Journal of Urology
Central European Journal of Urology UROLOGY & NEPHROLOGY-
CiteScore
2.30
自引率
8.30%
发文量
48
期刊最新文献
Transperitoneal single-port robotic Firefly-guided bladder diverticulectomy and simple prostatectomy. Extracorporeal shock wave lithotripsy, ureterolithotripsy, and percutaneous nephrolithotripsy challenges in managing spinal cord neuropathy patients. Lessons learned from a scoping review. Robotic left nephrectomy with level IV inferior vena cava thrombectomy using the AngioVac system. Detrusor underactivity in symptomatic anterior pelvic organ prolapse. The role of gel-infused translabial ultrasound as a new modality in evaluation of female urethral stricture.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1